You might have heard news reports this week of Central Iowa authorities cracking down on CBD-infused products. You might have also heard claims that CBD “kills cancer cells,” provides alternative “treatment” for Alzheimer’s disease, or “controls” blood sugar in diabetics. You might even have read the Business Record’s coverage of CBD-infused products in Iowa industry. Now, read Politico’s exploration of where CBD’s burgeoning popularity leaves it along the legal lines: Does the FDA have the authority it says it does? Who is ensuring the CBD being sold is derived from legalized hemp? Will pharmaceutical companies invest in research if it’s available over the counter? What research is backing up those internet claims?